Abstract
We report the case of a 78-year-old man diagnosed with metastatic renal cell carcinoma developping acute haemolysis under Sunitinib as well as under Sorafenib. This side effect induced a definitive withdrawal from the drugs. As these drugs are used more widely, rare side effects are bound to appear.
Original language | English |
---|---|
Pages (from-to) | 7-9 |
Number of pages | 3 |
Journal | Bulletin de la Société des Sciences Médicales du Grand-Duché de Luxembourg |
Issue number | 1 |
Publication status | Published - 2009 |
Externally published | Yes |